Avelumab demonstrates promise in advanced NSCLC
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.22418
Abstract: The JAVELIN Solid Tumor clinical trials group recently reported the results of a multi-center open-label phase 1b study (NCT01772004) evaluating avelumab in patients with progressive or platinum-resistant metastatic or recurrent non-small cell lung cancer (NSCLC)… read more here.
Keywords: adcc; nsclc avelumab; avelumab demonstrates; cell ... See more keywords